Episode 299: Androgen receptor ligand-di...

Toni Choueiri joins Brian and Tom to discuss a recent Nature paper regarding the novel HIF inhibitor, casdatifan, and biomarkers of response. 

Ari Hakimi and Lyn Voung from MSKCC join Brian and Tom to discuss their recent Cancer Cell paper exploring the mechanistic impact of TKI-induced hypoxia on immune response in RCC. 

Brian and Tom invite Neha Vapiwala, a Radiation Oncologist, to discuss areas of consensus and controversy from the PROTEUS trial of ADT +/- apalutamide in high-risk localized prostate cancer. 

<p>This is the first of a two part episode on prostate cancer. This episode will cover localized prostate cancer, including the diagnostic work-up, staging and treatment. </p> 

<p>Dr. Manisha Bahl discusses the role of DCFPyL PET/CT in patients with initially diagnosed and biochemically recurrent prostate cancer with Dr. Gary Ulaner. </p> <p><a href= "https://doi.org/10.1148/radiol.220218">¹⁸F-DCFPyL PET/CT for Initially Diagnosed and Biochem ... Show More

Send us Fan MailNinja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob break down the essential clinical and pathophysiologic features of Prostate Cancer, one of the most common malignancies affecting men worldwide.We begin with the epidemiology and risk factors, hig ... Show More

New research on prostate cancer screening and diet. This episode features audio from: The Pros and Cons of Testing PSA Levels for Prostate Cancer Changing a Man’s Diet After a Prostate Cancer Diagnosis Natural Dietary Treatments for Enlarged Prostate BPH Visit the video pages for ... Show More

Learn what you need to know about early-stage prostate cancer, from risk factors to treatment options and how to tackle their side effects. In this episode, Dr. Diane Reidy-Lagunes is joined by medical oncologist Dr. Dana Rathkopf, radiation oncologist Dr. Sean McBride, and urolo ... Show More

<p>Today’s episode is part 2 of our prostate cancer series, and will focus on the important details regarding treatment options for castrate sensitive and resistant prostate cancer.</p> 

Sarcoidosis (1:30), compression therapy in venous ulcers (4:30), FilmArray GI panel (6:30), medications for alcohol use disorder (10:00), removing erroneous penicillin allergy labels (14:50), and tadalafil for benign prostatic hyperplasia (16:50). 

PARP Inhibitors in Advanced Prostate Cancer Care Podcast CME Available: https://auau.auanet.org/node/37321 Host: Jay D. Raman, MD, FACS Guests: Maha Hussain, MD and Ganesh Raj, MD, PhD LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Identi ... Show More

Biomarkers and Molecular Imaging for Prostate Cancer CME Available: auau.auanet.org/node/41727 ACKNOWLEDGEMENTS: Support provided by independent educational grants from: Lantheus Medical Imaging Novartis Pharmaceuticals Corporation LEARNING OBJECTIVES: At the conclusion of this a ... Show More

In this episode, Dr Keith Rourke discusses the diagnosis and management of prostate cancer. After listening to this podcast, learners will be able to: discuss early detection of prostate cancer explain what PSA is list the treatment options for prostate cancer in its early and ad ... Show More